Inovio Pharmaceuticals Inc (INO)

[Ubertino]

Why Inovio Pharmaceuticals (INO) Could Be Positioned for a Surge?

June 10, 2015
by Zacks Equity Research Published on June 10, 2015

Inovio Pharmaceuticals, Inc. (INO - Analyst Report) is a biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on INO’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Inovio Pharmaceuticals could be a solid choice for investors.

Current Quarter Estimates for INO

In the past 30 days, 2 estimates have gone higher for Inovio Pharmaceuticals while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 21 cents a share 30 days ago, to a loss of 4 cents a share today, a move of 81%.

Current Year Estimates for INO

Meanwhile, Inovio Pharmaceuticals’ current year figures are also looking quite promising, with 3 estimates moving higher in the past month, compared to only 1 lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 70 cents per share 30 days ago to a loss of 62 cents per share today, a move of 11.4%.

Bottom Line

The stock has also started to move higher lately, adding 9.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.

http://www.nasdaq.com/article/why-inovio-pharmaceuticals-ino-could-be-positioned-for-a-surge-tale-of-the-tape-cm485578